Zahoor khan
Quick facts
Phase 3 pipeline
- Group III - Serratiopeptidase Group · Inflammation, Pain Management, Orthopedics
Serratiopeptidase is a serine protease enzyme that breaks down non-structural proteins and fibrin, reducing inflammation and promoting tissue repair.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Zahoor khan
What is Zahoor khan's pipeline?
Zahoor khan has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Group III - Serratiopeptidase Group.
Related
- Sector hub: All tracked pharma companies